EUVIMEDEUVIMED entdecken
Open Access

Multimorbidity Is Associated With Symptom Severity and Disease Progression in Patients with Paroxysmal Atrial Fibrillation—Data From the RACE V Study

Colinda van Deutekom iD, Martijn E van de Lande iD, Rajiv Rama iD, Bao-Oanh Nguyen iD, Robert G Tieleman, Vanessa Weberndörfer, Martin E W Hemels iD, Mirko de Melis iD, Ulrich Schotten iD, Dominik Linz, Harry J G M Crijns iD, Isabelle C van Gelder iD und 2 weitere

Journal of the American Heart Association · 04.03.2025 · 14 (5)

DOI: 10.1161/jaha.123.034514 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Heart Association, erschienen am 04.03.2025. Verfasst von Colinda van Deutekom und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, University of Groningen University Medical Centre Groningen The Netherlands. Hauptthemen laut MEDLINE: Atrial Fibrillation. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background Multimorbidity is common among patients with atrial fibrillation (AF) and is associated with worse outcomes. We aimed to investigate the association between multimorbidity, AF progression and AF symptom severity in patients with paroxysmal AF. Methods and Results The RACE V (Reappraisal of AF: Interaction Between Hypercoagulability, Electrical Remodeling, and Vascular Destabilization in the Progression of AF) study included patients with paroxysmal AF and continuous rhythm monitoring. Multimorbidity was defined as ≥2 comorbidities (heart failure, hypertension, diabetes, coronary heart disease, kidney dysfunction, moderate or severe mitral valve regurgitation, or obesity). AF symptom severity was assessed via the University of Toronto AF Severity Scale questionnaire. The associations between multimorbidity, AF progression, and AF symptom severity were determined using logistic regression analyses. Median age was 65 (58–71) years and 179 of 417 patients (43%) were women, with a median of 1 (1–2) comorbidities. Median follow‐up was 2.2 (1.6–2.8) years. Multimorbidity was associated with AF progression (odds ratio [OR], 2.02 [95% CI, 1.10–3.72], P =0.024) and increased AF symptom severity (OR, 2.67 [95% CI, 1.79–3.99], P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationAgedFemaleHumansMaleMiddle AgedComorbidityDisease ProgressionMultimorbidityRisk FactorsSeverity of Illness IndexUnited States

Stichwörter der Autor:innen

atrial fibrillationcomorbiditiesmultimorbidityprogressionsymptom severity

Autor:innen und Institutionen

  • Department of Cardiology, University of Groningen University Medical Centre Groningen The Netherlands.
  • Department of Cardiology Martini Hospital Groningen The Netherlands.
  • Department of Cardiology Maastricht University Medical Centre+ Maastricht The Netherlands.
  • Cardiovascular Research Institute Maastricht (CARIM) Maastricht University Maastricht The Netherlands.
  • Department of Cardiology Rijnstate Hospital Arnhem The Netherlands.
  • Medtronic Bakken Research Centre Maastricht The Netherlands.

ORCID-Profile: Colinda van Deutekom, Martijn E van de Lande, Rajiv Rama, Bao-Oanh Nguyen, Martin E W Hemels, Mirko de Melis, Ulrich Schotten, Harry J G M Crijns, Isabelle C van Gelder, Michiel Rienstra

Zitieren

APA

van Deutekom, C., van de Lande, M. E., Rama, R., Nguyen, B. O., Tieleman, R. G., Weberndörfer, V., Hemels, M. E. W., de Melis, M., Schotten, U., Linz, D., Crijns, H. J. G. M., van Gelder, I. C., Rienstra, M., & RACE V Investigators (2025). Multimorbidity Is Associated With Symptom Severity and Disease Progression in Patients with Paroxysmal Atrial Fibrillation—Data From the RACE V Study. Journal of the American Heart Association, 14(5). https://doi.org/10.1161/jaha.123.034514

Vancouver

van Deutekom C, van de Lande ME, Rama R, Nguyen BO, Tieleman RG, Weberndörfer V, et al. Multimorbidity Is Associated With Symptom Severity and Disease Progression in Patients with Paroxysmal Atrial Fibrillation—Data From the RACE V Study. Journal of the American Heart Association. 2025;14(5). doi:10.1161/jaha.123.034514

BibTeX
@article{vanDeutekom2025,
  author = {van Deutekom, Colinda and van de Lande, Martijn E and Rama, Rajiv and Nguyen, Bao-Oanh and Tieleman, Robert G and Weberndörfer, Vanessa and Hemels, Martin E W and de Melis, Mirko and Schotten, Ulrich and Linz, Dominik and Crijns, Harry J G M and van Gelder, Isabelle C and Rienstra, Michiel and RACE V Investigators, RACE V Investigators},
  title = {Multimorbidity Is Associated With Symptom Severity and Disease Progression in Patients with Paroxysmal Atrial Fibrillation—Data From the RACE V Study},
  journal = {Journal of the American Heart Association},
  year = {2025},
  volume = {14},
  number = {5},
  doi = {10.1161/jaha.123.034514}
}
Kostenlos starten →